SCHEMBL9059409

SCHEMBL9059409

CN1CCN(C(=N)Nc2ccccc2-c2ccccc2F)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 8/20 0.47
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KDM1A O60341 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
KMT2A Q03164 1/20 0.41
CSF1R P07333 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
MAP4K1 Q92918 1/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
RAB9A P51151 1/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9538982 0.92 CHRM3 (0.47) CHRM3KDM4EALDH1A1HSD17B10KDM1A
Fumaric Acid SCHEMBL9311361 0.91 CHRM3 (0.46) CHRM3KDM4EALDH1A1HSD17B10KDM1A
SCHEMBL9059781 0.84 CHRM3 (0.53) CHRM3KDM4EALDH1A1HSD17B10KMT2A
SCHEMBL9059576 0.82 CHRM3 (0.44) CHRM3ALDH1A1KMT2AMAP4K1MAPT
SCHEMBL9059856 0.82 CHRM3 (0.53) CHRM3KDM4EALDH1A1HSD17B10KDM1A
SCHEMBL9536114 0.80 CHRM3 (0.47) CHRM3KDM4EALDH1A1KMT2AMAPT
SCHEMBL17777318 0.78 KDM4E (0.47) KDM4EALDH1A1HSD17B10KMT2ATDP1
SCHEMBL9059333 0.77 CHRM3 (0.52) CHRM3KDM4E
SCHEMBL9059940 0.75 CHRM3 (0.48) CHRM3KDM4EALDH1A1KDM1AMAOA
Fumaric Acid SCHEMBL9312680 0.74 KDM4E (0.45) CHRM3KDM4EALDH1A1KMT2AMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed